Fig. 6

Adverse events in the study participants receiving intravitreal injection of BM-MSCs. a Slit-lamp biomicroscopy of a study participant with posterior synechiae (indicated by arrows). b After treatment with the cycloplegic agent, the posterior synechiae were released, leaving some residual pigments adhered on the lens surface (indicated by the arrow). c Optical coherence tomography imaging in a study participant at baseline and d at month 3 with mild cystoid macular edema (indicated by the arrow). e The ultra-widefield retinal imaging shows choroidal detachment (indicated by arrows) at the superotemporal periphery. f Ultrasound imaging demonstrates double-peak reflectivity (indicated by arrows) with anechoic suprachoroidal space